Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ETI-104 Heteropolymer: Phase I

In a German Phase I trial in 8 healthy volunteers,

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE